Reduced TGF-beta1 expression and its target genes in human insulinomas
| Autor: | W Gartner, G. Vila, Ludwig Wagner, Wolfgang Base, Anastasiya Nabokikh, Aysegul Ilhan, Oswald Wagner, Anton Luger, Bruno Niederle, Jens Høiriis Nielsen, Martin Bilban |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
endocrine system
medicine.medical_specialty Pancreatic disease endocrine system diseases Endocrinology Diabetes and Metabolism Biology Transforming Growth Factor beta1 Islets of Langerhans Endocrinology Internal medicine Internal Medicine medicine Humans Insulinoma Oligonucleotide Array Sequence Analysis Regulation of gene expression Reverse Transcriptase Polymerase Chain Reaction Pancreatic islets Gene Expression Profiling General Medicine Transforming growth factor beta medicine.disease Neoplasm Proteins Gene expression profiling Gene Expression Regulation Neoplastic medicine.anatomical_structure Cancer research biology.protein Transforming growth factor TGFBI Carcinoma Pancreatic Ductal Signal Transduction |
| Zdroj: | Experimental and clinical endocrinologydiabetes : official journal, German Society of Endocrinology [and] German Diabetes Association. 115(10) |
| ISSN: | 0947-7349 |
| Popis: | Aiming to identify signalling pathways relevant for ss-cell growth we performed an explorative micro-array analysis comparing the gene expression profiles of three human insulinomas and one normal pancreatic islet preparation. This revealed an insulinoma-associated down-regulation of the transforming growth factor beta 1 (TGF-beta1) and its target genes. Comparative quantitative real-time PCR (qRT-PCR) including an expanded sample number of both insulinomas (n=9) and pancreatic islet preparations (n=4) confirmed the decreased TGF-beta1 expression and its target molecules (TGFBI, NNMT, RPN2) in insulinomas. Similarly, TGF-beta1 immunofluorescence analysis revealed reduced expression in insulinomas when compared to pancreatic islets. In contrast, TGFBR2 (transforming growth factor beta receptor II) was found up-regulated. However, the consistent down-regulation of the TGF-beta1 targets TGFBI (transforming growth factor, beta-induced), NNMT (nicotinamide N-methyltransferase), RPN2 (ribophorin II) indicates that the parallel up-regulation of TGFBR2 does not compensate for the only marginal TGF-beta1 expression levels in insulinomas. TGFBR2 expression was confirmed at the protein level in insulinomas. SMAD2/3 protein expression was found at higher levels in human pancreatic islets when compared with insulinomas by dual colour confocal microscopy. TGF-beta1 signalling is known to be involved in cell replication and is abrogated in ductal pancreatic tumours. The down-regulation of TGF-beta1 expression and its target molecules in insulinomas is a new aspect of this cytokine. Our data underline parallels in endocrine and exocrine pancreatic tumour development, which may implicate common progenitor cells. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|